State of the art and future directions in nanomedicine for tuberculosis.

@article{Dube2013StateOT,
  title={State of the art and future directions in nanomedicine for tuberculosis.},
  author={Admire Dube and Yolandy Lemmer and Rose Hayeshi and M Adekoyejo Balogun and Philip W Labuschagne and Hulda Shaidi Swai and Lonji Kalombo},
  journal={Expert opinion on drug delivery},
  year={2013},
  volume={10 12},
  pages={1725-34}
}
INTRODUCTION Tuberculosis (TB) ranks the second leading cause of death from an infectious disease worldwide. However, treatment of TB is affected by poor patient compliance due to the requirement for daily drug administration, for lengthy periods of time, often with severe drug-induced side effects. Nanomedicines have the potential to improve treatment outcomes by providing therapies with reduced drug doses, administered less frequently, under shortened treatment durations. AREAS COVERED In… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…